Successful Conclusion! Bright Moon Shines at CPHI Japan 2025 with High-Quality MOONITOL? Mannitol, Exploring New Opportunities for Pharmaceutical Innovation & Cooperation
2025-04-24
The highly anticipated global pharmaceutical industry event, CPHI Japan 2025, recently concluded successfully in Tokyo. As a leading enterprise deeply rooted in marine biotechnology, Qingdao Bright Moon Seaweed Group Co., Ltd. showcased its high-quality pharmaceutical excipient portfolio, joining global pharmaceutical professionals to discuss collaborations and future prospects.
Focusing on Core Strengths, Star Product MOONITOL? Mannitol Garners Significant Attention
At this exhibition, Qingdao Bright Moon Seaweed Group focused on its core strengths, highlighting the exceptional performance and wide applications of our pharmaceutical-grade mannitol. As an indispensable key excipient in oral solid dosage forms, MOONITOL? Mannitol attracted significant interest from numerous domestic and international clients for consultations and in-depth discussions. Especially highlighted were our two flagship series meticulously designed for diverse application needs:
MOONITOL? SD: Highly favored for its excellent "High Flowability, Strong Binding" properties, making it the ideal choice for efficient direct compression processes.
MOONITOL? C: With its outstanding advantages of "Sugar-free, Non-hygroscopic & Perfectly Stable," it provides reliable assurance for achieving superior performance, catering to clients focused on product stability and special formulation requirements.
These solutions, precisely meeting market demands, combined with the consistent exceptional quality, stable supply, and global compliance of MOONITOL? Mannitol, garnered high attention and recognition from attendees.
Engaging Dialogues, Exploring Future Industry Trends
During the exhibition, the Bright Moon Seaweed booth attracted significant attention, fostering a lively yet professional atmosphere for exchange. Mr. Zhang Guofang, Chairman of Qingdao Bright Moon Seaweed Group, personally visited the booth, engaging genuinely with clients and underscoring Bright Moon's "customer-centric" service philosophy.
Our professional team also engaged in productive discussions with partners from the global pharmaceutical community. Topics ranged from the innovative applications of mannitol in dosage forms like tablets, granules, chewable tablets, and oral dissolving films, to performance optimization and regulatory strategies. These in-depth discussions were a constant theme, laying a solid foundation for future collaborations.
Clients highly praised Bright Moon Seaweed for its stringent product quality control, robust R&D capabilities, and tailored service competence, expressing strong interest in future cooperation. The event not only strengthened partnerships with existing clients but also allowed us to establish numerous new connections, providing significant momentum for expanding into the Japanese and Asia-Pacific markets.
Gratitude for Partnership, Advancing Towards a Healthier Future Together
Though the exhibition has concluded, our collaboration continues. Qingdao Bright Moon Seaweed will remain committed to its mission of "Utilizing Marine Resources, Safeguarding Human Health," continuously innovating and making breakthroughs. We are dedicated to providing the global pharmaceutical industry with superior, more reliable pharmaceutical excipient products and solutions, collectively contributing to the advancement of human health!
ABOUT BMSG
Established in 1968 in Qingdao,China,Bright Moon is a leading pioneer in the development and utilization of active ingredients from seaweed.
We advocate the business philosophy of "One Seaweed,Cultivating a Flourishing Health Industry".Bright Moon boasts a global presence with facilities and sales offices located in Chile,Qingdao,Jiangsu,and Shanghai.We possess the State Key Laboratory of Marine Food Processing & Safety Control and an R&D center in Shanghai.Our global network encompasses 14 subsidiaries,10 OEM/ODM manufacturing partners,and a workforce of over 2000 employees.
Bright Moon actively operates in seven major sectors:Food&Beverage,Animal Nutrition&Health,Personal Care,Biomedicine,Soil Nutrition&Health,Industrial Markets and Cultural Tourism.Through science and technology,products and services, we create value for the sustainable development of humans,animals,and the earth.Bright Moon is committed to utilizing marine resources to benefiting human health.
